| May 1, 2012 |
|
Diagnostic Testing & Technology Report
Everist Genomics Eyes Future Growth, International Expansion (pdf) |
| March 19, 2012 |
|
The Gray Sheet
Everist Genomics’ Colorectal Cancer Tests (pdf) |
| December 14, 2011 |
|
Xconomy
Ann Arbor’s Everist Genomics Develops New Tests for Cancer Risk |
| December 7, 2011 |
|
Mergermarket
Everist Genomics will seek up to USD 20m in funding, JVs next year, executive says (pdf) |
| December 7, 2011 |
|
Fierce Medical Devices
5 Innovative Michigan companies |
| November 14, 2011 |
|
Medical Device Daily
Everist launches 'smartphone' heart rhythm monitoring system
|
| November 11, 2011 |
|
Fast Company
Coming Soon: A Hospital Quality EKG on Your Smartphone |
| November 9, 2011 |
|
MedGadget
CardioDefender Smartphone-based ECG, a 21st Century Holter Monitor |
| November 7, 2011 |
|
BioCentury
Angiologix Inc., Everist Genomics deal |
| October 31, 2011 |
|
CBS Detroit
Ann Arbor’s Everist Genomics Buys Angiologix Inc.
|
| August 26, 2011 |
|
GenomeWeb Daily News
Genetic Testing Firms Tout Underlying Bioinformatics Capabilities as Key Business Component |
| April 13, 2011 |
|
Medical Device Daily
Everist hits the market with its colorectal cancer assay (pdf) |
| April 1, 2011 |
|
The Oncology Report
Molecular Tests Focus on Need for Aggressive Therapy |
| March 1, 2011 |
|
Internal Medicine News
Molecular Markers Predict Need For Adjuvant Treatment of Colon Cancer |
| March 1, 2011 |
|
Gastroenterology & Endoscopy News
Gene Tests Predict Risk, Guide Therapy for Patients With Stage I-III Colon Cancer |
| March 1, 2011 |
|
PharmaVoice
Everist Genomics Appoints President and CEO |
| January 26, 2011 |
|
Medical Device Daily
Study validates colorectal cancer recurrence test from Everist |
| January 20, 2011 |
|
Medscape
More Genetic Tests to Predict Recurrence in Stage II Colon |
